Tsubota Laboratory Incorporated

4890 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥257.00
-3.38%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.53.
  • Current assets comfortably cover current liabilities (current ratio 3.14).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -1,128.7 times.
  • Return on equity is on the lower side at -88.2%.
  • Return on capital employed is on the lower side at -86.5%.
  • The company reported a net loss in the latest period.
  • Sales growth has been slow over five years (about -25% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-1.88

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
1 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥66億
Current Price¥ 257.00
High / Low¥ 478.00 / 210.00
Stock P/E-8.69
Book Value¥ 33.49
Dividend Yield0%
ROCE-86.50%
ROE-88.19%
Debt to Equity0.53
Current Ratio3.14
P/B Ratio9.03371
EPS¥ -29.58
PAT Margin-380.87%
ICR-1128.68
Compounded Sales Growth
10 Years
5 Years -25.26%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year -88.19%
Educational data only. Not a recommendation to buy, sell or hold any security.